ARIA Precision Neurotechnologies

# ARIA Precision Neurotechnologies **Entity class:** Organization or institution **Collection:** [[collections/Neurotech|Neurotech]] ## Definition **ARIA Precision Neurotechnologies** is an organization or institution. ARIA Precision Neurotechnologies received funding from Advanced Research + Invention Agency (ARIA). £69m current program envelope. ARIA Precision Neurotechnologies is associated with 19 teams across academia, nonprofits and startups. Current 2026 program page; initial 2025 announcement described 18 teams. ARIA Precision Neurotechnologies is associated with non-invasive interfaces. The entry centers on the organization's documented work, partners, users, and institutional lineage, so its own role remains distinct from the roles of adjacent programs and technologies. ## Relationships  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Funding, business, and licensing - **ARIA Precision Neurotechnologies** received funding from Advanced Research + Invention Agency (ARIA). £69m current program envelope. - **ARIA Precision Neurotechnologies** is associated with £69 million. 19 teams; four workstreams. ### Key Relationships - **ARIA Precision Neurotechnologies** is associated with 19 teams across academia, nonprofits and startups. Current 2026 program page; initial 2025 announcement described 18 teams. - **ARIA Precision Neurotechnologies** is associated with non-invasive interfaces. - **ARIA Precision Neurotechnologies** is associated with remote interfaces. - **ARIA Precision Neurotechnologies** is associated with biological interfaces. - **ARIA Precision Neurotechnologies** is associated with future adoption of novel neurotechnologies. - **ARIA Precision Neurotechnologies** is identified with the project [[wiki/High-Precision Non-Invasive Multi-Focal Bidirectional Acoustoelectric Neural Interface|High-Precision Non-Invasive Multi-Focal Bidirectional Acoustoelectric Neural Interface]]. Oscar Calderon Agudo; Sonalis Imaging + Imperial College London. - **ARIA Precision Neurotechnologies** is identified with the project [[wiki/Minimally Invasive Multiplexed Temporal Interference Brain Stimulation Network|Minimally Invasive Multiplexed Temporal Interference Brain Stimulation Network]]. - **ARIA Precision Neurotechnologies** is identified with the project Next-Generation Brain-Machine Interface for Whole-Brain I/O. Aimun Jamjoom / Barking, Havering and Redbridge University Hospitals Trust. - **ARIA Precision Neurotechnologies** is identified with the project [[wiki/Brain Mesh|Brain Mesh]]. Jacob Robinson / Motif Neurotech + Rice University. ### Technology and research relationships - **ARIA Precision Neurotechnologies** is associated with **nanotransducer networks controlled by external magnetic, optical or acoustic fields**. Programme thesis search space; strong modern parallel to DARPA N3. - **ARIA Precision Neurotechnologies** is associated with **next-generation focused ultrasound neuromodulation and recording**. - **ARIA Precision Neurotechnologies** is associated with cell-type-specific gene therapies and blood-based neuromodulation/monitoring. ### Additional Documented Relationships - **ARIA Precision Neurotechnologies** received funding from [[wiki/Advanced Research and Invention Agency|Advanced Research and Invention Agency]]. £69m current program envelope. - **ARIA Precision Neurotechnologies** is associated with [[wiki/Biohybrid Neural Systems|Biohybrid Neural Systems]]. - **ARIA Precision Neurotechnologies** is identified with the project [[wiki/Next-Generation Brain-Machine Interface for Whole-Brain I and O|Next-Generation Brain-Machine Interface for Whole-Brain I and O]]. Aimun Jamjoom / Barking. Havering and Redbridge University Hospitals Trust.  ## Research Edges  #### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 193 — `funded_by` → [[wiki/Advanced Research and Invention Agency|Advanced Research + Invention Agency (ARIA)]]** — **VERIFIED**; evidence `ARIA_PRECISION`. £69m current program envelope. - **Edge 194 — `current_portfolio` → 19 teams across academia, nonprofits and startups** — **VERIFIED**; evidence `ARIA_PROJECTS`. Current 2026 program page; initial 2025 announcement described 18 teams. - **Edge 195 — `workstream` → [[wiki/Non-Invasive BCI|non-invasive interfaces]]** — **VERIFIED**; evidence `ARIA_PROJECTS`. - **Edge 196 — `workstream` → remote interfaces** — **VERIFIED**; evidence `ARIA_PROJECTS`. - **Edge 197 — `workstream` → [[wiki/Biohybrid Neural Systems|biological interfaces]]** — **VERIFIED**; evidence `ARIA_PROJECTS`. - **Edge 198 — `workstream` → future adoption of novel neurotechnologies** — **VERIFIED**; evidence `ARIA_PROJECTS`. - **Edge 199 — `explicit_candidate_technology` → nanotransducer networks controlled by external magnetic, optical or acoustic fields** — **VERIFIED**; evidence `ARIA_PRECISION`. Programme thesis search space; strong modern parallel to DARPA N3. - **Edge 200 — `explicit_candidate_technology` → next-generation focused ultrasound neuromodulation and recording** — **VERIFIED**; evidence `ARIA_PRECISION`. - **Edge 201 — `explicit_candidate_technology` → cell-type-specific gene therapies and blood-based neuromodulation/monitoring** — **VERIFIED**; evidence `ARIA_PRECISION`. - **Edge 202 — `project` → [[wiki/High-Precision Non-Invasive Multi-Focal Bidirectional Acoustoelectric Neural Interface|High-Precision Non-Invasive Multi-Focal Bidirectional Acoustoelectric Neural Interface]]** — **VERIFIED**; evidence `ARIA_PROJECTS`. Oscar Calderon Agudo; Sonalis Imaging + Imperial College London. - **Edge 203 — `project` → [[wiki/Minimally Invasive Multiplexed Temporal Interference Brain Stimulation Network|Minimally Invasive Multiplexed Temporal Interference Brain Stimulation Network]]** — **VERIFIED**; evidence `ARIA_PROJECTS`. Nir Grossman / UK Dementia Research Institute at Imperial. - **Edge 204 — `project` → [[wiki/Next-Generation Brain-Machine Interface for Whole-Brain Input-Output|Next-Generation Brain-Machine Interface for Whole-Brain I/O]]** — **VERIFIED**; evidence `ARIA_PROJECTS`. Aimun Jamjoom / Barking, Havering and Redbridge University Hospitals Trust. - **Edge 205 — `project` → [[wiki/Brain Mesh|Brain Mesh]]** — **VERIFIED**; evidence `ARIA_PROJECTS`. Jacob Robinson / Motif Neurotech + Rice University.   #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 193 — `funded_by` → Advanced Research + Invention Agency (ARIA)** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`. £69m current program envelope. - **Edge 194 — `current_portfolio` → 19 teams across academia, nonprofits and startups** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`. Current 2026 program page; initial 2025 announcement described 18 teams. - **Edge 195 — `workstream` → non-invasive interfaces** — **VERIFIED_PRIMARY**; evidence `ARIA_PROJECTS`, `ARIA_CURRENT_PROJECTS`. - **Edge 196 — `workstream` → remote interfaces** — **VERIFIED_PRIMARY**; evidence `ARIA_PROJECTS`, `ARIA_CURRENT_PROJECTS`. - **Edge 197 — `workstream` → biological interfaces** — **VERIFIED_PRIMARY**; evidence `ARIA_PROJECTS`, `ARIA_CURRENT_PROJECTS`. - **Edge 198 — `workstream` → future adoption of novel neurotechnologies** — **VERIFIED_PRIMARY**; evidence `ARIA_PROJECTS`, `ARIA_CURRENT_PROJECTS`. - **Edge 199 — `explicit_candidate_technology` → **nanotransducer networks controlled by external magnetic, optical or acoustic fields**** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`. Programme thesis search space; strong modern parallel to DARPA N3. - **Edge 200 — `explicit_candidate_technology` → **next-generation focused ultrasound neuromodulation and recording**** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`. - **Edge 201 — `explicit_candidate_technology` → **cell-type-specific gene therapies and blood-based neuromodulation/monitoring**** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`. - **Edge 202 — `project` → [[wiki/High-Precision Non-Invasive Multi-Focal Bidirectional Acoustoelectric Neural Interface|High-Precision Non-Invasive Multi-Focal Bidirectional Acoustoelectric Neural Interface]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`. Oscar Calderon Agudo; Sonalis Imaging + Imperial College London. - **Edge 203 — `project` → [[wiki/Minimally Invasive Multiplexed Temporal Interference Brain Stimulation Network|Minimally Invasive Multiplexed Temporal Interference Brain Stimulation Network]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`. Nir Grossman / UK Dementia Research Institute at Imperial. - **Edge 204 — `project` → [[wiki/Next-Generation Brain-Machine Interface for Whole-Brain I and O|Next-Generation Brain-Machine Interface for Whole-Brain I/O]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`. Aimun Jamjoom / Barking, Havering and Redbridge University Hospitals Trust. - **Edge 205 — `project` → [[wiki/Brain Mesh|Brain Mesh]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`. Jacob Robinson / Motif Neurotech + Rice University. - **Edge 795 — `funding` → £69 million** — **VERIFIED_PRIMARY**; evidence `ARIA_CURRENT_PROJECTS`. 19 teams; four workstreams.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0453 — Established.** Research nonprofits producing for-profit spin-outs with overlapping founders is a repeated and documented pattern in this sector. The structure moves publicly or philanthropically funded capability into private hands lawfully and quickly, and it recurs because it works. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0454 — Established.** The UK agency modeled on high-risk research funding sits upstream of interface work that has since been capitalized in the United States. State research money crossing borders into private capability is an ordinary and traceable flow. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0455 — Established.** Concentrated authority in a program manager with a fixed term and a specific objective is the mechanism behind the agency's record. Copying the structure — as ARIA and ARPA-H have — reproduces the capability, which is why the model proliferates. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0462 — Analytic.** Every frontier capability has a component with one or two credible suppliers, whether lithography, cell lines, or reagents. Chokepoint identification is the practical form of strategic analysis in any technology sector, and it applies unchanged to neurotechnology. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0465 — Strongly indicated.** Substantial neural-interface and brain-mapping programs operate outside the American reporting environment, with their own trials, companies, and standards participation. Visibility in English-language press is not a measure of capability, and native-language sourcing is required for an accurate picture. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0468 — Established.** Small, capable jurisdictions with strong institutions attract first deployments of novel infrastructure because the regulatory conversation is tractable. Deployment geography is chosen for governance characteristics as much as for technical ones. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0474 — Strongly indicated.** Solicitations, awards, and contract line items are public and specify capability requirements in technical detail. Procurement documents are the highest-quality public source on state intent and are consistently underused. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]]  ## Integrated Relationship Records ### cell-type-specific gene therapies and blood-based neuromodulation and monitoring The relationship value **cell-type-specific gene therapies and blood-based neuromodulation and monitoring** is integrated here because the September 10 graph import supplied it as `explicit_candidate_technology` of this subject, not as an independently named entity. Its complete active record follows, with headings demoted to preserve this page's hierarchy.  **Aliases:** cell-type-specific gene therapies and blood-based neuromodulation/monitoring **Entity class:** Technology, method, or technical system **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] #### Definition **cell-type-specific gene therapies and blood-based neuromodulation and monitoring** is a technology, method, or technical system. **ARIA Precision Neurotechnologies** is associated with **cell-type-specific gene therapies and blood-based neuromodulation and monitoring**. The entry centers on the technology's mechanism, implementation, applications, and technical lineage, keeping demonstrated capability separate from projected deployment. #### Relationships  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]]. Status-qualified source edges are preserved in the terminal Research Edges section. ##### Additional Documented Relationships - **ARIA Precision Neurotechnologies** is associated with **cell-type-specific gene therapies and blood-based neuromodulation and monitoring**.  #### Research Edges  ###### Consciousness mapping and transfer graph patch — 2026-09-10 **Resolved aliases:** `cell-type-specific gene therapies and blood-based neuromodulation/monitoring` **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] ###### Incoming typed edges - **Edge 201 — **ARIA Precision Neurotechnologies** `explicit_candidate_technology` → this entry** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`.  #### Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0326 — Established.** An infant with CPS1 deficiency received a bespoke base-editing therapy designed for his individual mutation, dosed in February 2025 — the first personalized in vivo gene-editing treatment in a human. The unit of therapy became one patient, which is a structural break with every prior drug development model. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0327 — Established.** A CHOP-and-Penn clinical-research pair designed, manufactured, and administered an individualized editing therapy inside a compressed timeline. The named individuals and their institutional pairing are the transfer mechanism by which bespoke editing became clinically real. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0328 — Established.** The FDA's February 2026 draft framework permits first-in-human studies for individualized genetic therapies on preclinical proof-of-concept and allows new targets under a single application. Regulatory throughput, not editing chemistry, was the binding constraint, and this guidance directly relaxes it. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0330 — Established.** Prime editing writes specified sequences without double-strand breaks, making the edit a parameter rather than a redesign. When the therapeutic is a string, therapy development becomes a software-like activity with software-like iteration speed. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0339 — Strongly indicated.** Delivering editing machinery across the blood-brain barrier is the single obstacle separating the editing toolkit from neurological application. Focused-ultrasound barrier opening and engineered capsids are two independent solutions already in clinical use. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0341 — Established.** Alignment with the FDA on biomarker-based accelerated approval for a base-editing therapy shortens the evidence timeline for the whole modality. Biomarker endpoints are how a slow-moving disease becomes a fast-moving clinical program. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0344 — Strongly indicated.** Contaminating plasmid sequences and disrupted vector genomes in the liver after AAV therapy demonstrate that manufacturing quality is a clinical variable. In individualized therapy, each patient's dose is a manufacturing run, which makes analytics the rate-limiting discipline. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0347 — Plausible.** A therapy specified as sequence data can be transmitted and synthesized near the patient rather than shipped. Manufacturing at the point of care is the logical endpoint of a fully digital therapeutic specification, and it makes distance irrelevant to treatment. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]]   ### nanotransducer networks controlled by external magnetic, optical or acoustic fields The relationship value **nanotransducer networks controlled by external magnetic, optical or acoustic fields** is integrated here because the September 10 graph import supplied it as `explicit_candidate_technology` of this subject, not as an independently named entity. Its complete active record follows, with headings demoted to preserve this page's hierarchy.  **Entity class:** Organization or institution **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] #### Definition **nanotransducer networks controlled by external magnetic, optical or acoustic fields** is an organization or institution. **ARIA Precision Neurotechnologies** is associated with **nanotransducer networks controlled by external magnetic, optical or acoustic fields**. Programme thesis search space; strong modern parallel to DARPA N3. The entry centers on the organization's documented work, partners, users, and institutional lineage, so its own role remains distinct from the roles of adjacent programs and technologies. #### Relationships  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ##### Technology and research relationships - **ARIA Precision Neurotechnologies** is associated with **nanotransducer networks controlled by external magnetic, optical or acoustic fields**. Programme thesis search space; strong modern parallel to DARPA N3.  #### Research Edges  ###### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] ###### Incoming typed edges - **Edge 199 — **ARIA Precision Neurotechnologies** `explicit_candidate_technology` → this entry** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`. Programme thesis search space; strong modern parallel to DARPA N3.   ### next-generation focused ultrasound neuromodulation and recording The relationship value **next-generation focused ultrasound neuromodulation and recording** is integrated here because the September 10 graph import supplied it as `explicit_candidate_technology` of this subject, not as an independently named entity. Its complete active record follows, with headings demoted to preserve this page's hierarchy.  **Entity class:** Concept or analytic term **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] #### Definition **next-generation focused ultrasound neuromodulation and recording** is a concept or analytic term. **ARIA Precision Neurotechnologies** is associated with **next-generation focused ultrasound neuromodulation and recording**. The entry centers on the concept's meaning, practical use, and boundaries, together with the examples that make the distinction operational rather than merely verbal. #### Relationships  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ##### Technology and research relationships - **ARIA Precision Neurotechnologies** is associated with **next-generation focused ultrasound neuromodulation and recording**.  #### Research Edges  ###### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] ###### Incoming typed edges - **Edge 200 — **ARIA Precision Neurotechnologies** `explicit_candidate_technology` → this entry** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PRECISION`.  #### Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0032 — Established.** Focused ultrasound with microbubbles opens the blood-brain barrier transiently and reversibly at a chosen location, which makes systemic delivery locally targetable. That single capability converts the vasculature into a delivery bus addressed by an external transducer. - **Canonical cluster:** [[wiki/Molecular Neural Interfaces|molecular neural interfaces]] - **INF-0033 — Analytic.** Functional ultrasound reads blood-flow dynamics, a proxy signal with seconds-scale physics, and any interface built on it inherits that time constant. The forward path is not faster hemodynamics but hybrid operation — acoustic read of slow state, molecular read of fast events. - **Canonical cluster:** [[wiki/Molecular Neural Interfaces|molecular neural interfaces]] - **INF-0038 — Analytic.** Acoustoelectric sensing uses ultrasound to tag the location of electrical activity, recovering spatial precision from a diffuse electrical measurement. It is the only current approach that promises electrode-grade localization with no electrode, and British state research funding is upstream of it. - **Canonical cluster:** [[wiki/Molecular Neural Interfaces|molecular neural interfaces]] - **INF-0044 — Plausible.** Transcranial focused ultrasound already modulates deep structures without genetic modification, which gives the modality a clinical on-ramp independent of sonogenetics. The therapy indication funds the hardware, and the hardware is the same hardware the interface needs. - **Canonical cluster:** [[wiki/Molecular Neural Interfaces|molecular neural interfaces]] - **INF-0045 — Plausible.** Molecular recorders that write neural activity into DNA inside the cell would remove bandwidth from the readout path entirely: the record is made locally and read once, later, by sequencing. That inverts the entire acquisition architecture and makes whole-population recording a sequencing-cost problem. - **Canonical cluster:** [[wiki/Molecular Neural Interfaces|molecular neural interfaces]]